Softwr

Healthcare · head to head

Lunit vs Philips IntelliSpace PACS

Lunit logo

Lunit

Healthcare

FDA cleared and CE marked AI for mammography, tomosynthesis and chest radiography

From
On request
Rated
-
Full reviewWebsite
Philips IntelliSpace PACS logo

Philips IntelliSpace PACS

Healthcare

Enterprise radiology PACS and diagnostic image viewing from Philips

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Lunit the regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.; Philips IntelliSpace PACS philips has consolidated its imaging marketing under Philips Enterprise Imaging and several IntelliSpace PACS regional pages now redirect to a generic medical imaging page, so a buyer signing a long PACS term should demand a written product lifecycle and version support statement before committing.
  • They diverge on capability: Lunit covers Lunit INSIGHT MMG, Philips IntelliSpace PACS covers Diagnostic reading client.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Lunit and Philips IntelliSpace PACS actually diverge.

Attributes where Lunit and Philips IntelliSpace PACS differ
AttributeLunitPhilips IntelliSpace PACS
PlatformsWebWeb, Windows

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Lunit

  • Lunit INSIGHT MMG
  • Lunit INSIGHT DBT
  • Lunit INSIGHT CXR
  • Volpara density assessment
  • Volpara RiskPathways
  • Volpara dose tracking
  • PACS and mammography workstation integration

Only in Philips IntelliSpace PACS

  • Diagnostic reading client
  • Zero footprint web viewer
  • Enterprise archive
  • Advanced visualisation
  • IntelliSpace Radiology on AWS
  • Worklist and workflow
  • AI results integration

What people use each for

The jobs each tool is most often brought in to do.

Lunit

  • A national breast screening programme evaluating AI as a second reader to reduce double reading workload where two human readers are currently mandatednot Philips IntelliSpace PACS
  • A breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on DBT specificallynot Philips IntelliSpace PACS
  • An American breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what Volpara is bought fornot Philips IntelliSpace PACS
  • A tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise filmsnot Philips IntelliSpace PACS

Philips IntelliSpace PACS

  • A hospital replacing an end of life PACS that already runs a large Philips CT and MR estate and wants modality and reading integration in one support contractnot Lunit
  • A radiology group consolidating several departmental archives into one enterprise archive with a single radiologist worklistnot Lunit
  • A health system that wants to move diagnostic reading off local workstations into a cloud hosted environment via the AWS listingnot Lunit
  • Sites that need server side advanced visualisation so radiologists can do 3D and vessel work without dedicated 3D workstationsnot Lunit

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Lunit

  • The regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • Detection AI changes recall rates in screening, and the downstream cost of additional diagnostic workup lands on the programme rather than on the software budget, which is the cost most screening business cases omit.
  • Performance is sensitive to the mammography vendor and acquisition protocol, so published results from a Hologic estate do not transfer to a GE or Siemens estate without local validation the buyer must fund.
  • MMG, DBT and CXR are licensed separately and Volpara modules are separate again, so a breast centre wanting detection, density and risk pathways is assembling four line items rather than buying one product.
  • Using AI as a replacement for one of two human readers is a workforce and liability decision that regulators and professional bodies treat differently in each country, so the saving that justifies the purchase may not be permitted where you operate.

Philips IntelliSpace PACS

  • Philips has consolidated its imaging marketing under Philips Enterprise Imaging and several IntelliSpace PACS regional pages now redirect to a generic medical imaging page, so a buyer signing a long PACS term should demand a written product lifecycle and version support statement before committing.
  • Advanced visualisation is licensed by concurrent user separately from the base PACS, so a department that sizes concurrency from average use finds radiologists blocked at the morning peak and buys more licences after go live.
  • The deepest integration is with Philips modalities, so sites running mixed GE and Siemens scanner fleets get less of the workflow benefit than the demonstration environment implies.
  • Third party AI findings arrive through a results interface rather than natively in the hanging protocol, so radiologists context switch to see algorithm output and adoption of purchased AI is lower than expected.
  • Data migration from a legacy PACS is a separate, large and often underquoted professional services line, and migrations of a decade of priors routinely run longer than the go live plan allows.

Pricing, plan by plan

Lunit

On request
  • Lunit INSIGHT$undefined/year
    • Priced per study or per annual examination volume by product
    • MMG, DBT and CXR licensed separately
    • Volpara density and RiskPathways modules quoted separately

Philips IntelliSpace PACS

On request
  • IntelliSpace PACS$undefined/year
    • Priced by annual study volume and concurrent diagnostic users
    • Advanced visualisation licensed separately by concurrent user
    • Storage and archive tiering priced by capacity

Which should you pick?

Choose Lunit if

  • You need lunit insight mmg.
  • You also want lunit insight dbt.
Lunit review

Choose Philips IntelliSpace PACS if

  • You need diagnostic reading client.
  • You work on Web, Windows.
  • You also want zero footprint web viewer.
Philips IntelliSpace PACS review

Questions people ask

Is Lunit or Philips IntelliSpace PACS better?
Neither clearly leads. Lunit starts at On request and Philips IntelliSpace PACS at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Lunit or Philips IntelliSpace PACS?
Lunit starts at On request and Philips IntelliSpace PACS at On request.
Does Lunit or Philips IntelliSpace PACS run on more platforms?
Lunit runs on Web. Philips IntelliSpace PACS runs on Web, Windows.
What is Lunit best used for?
Lunit is most often used for a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated, a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically, an american breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what volpara is bought for, a tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise films. Of those, a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated and a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically are not what Philips IntelliSpace PACS is typically brought in for.
What can Lunit do that Philips IntelliSpace PACS cannot?
Lunit covers Lunit INSIGHT MMG, Lunit INSIGHT DBT, Lunit INSIGHT CXR, Volpara density assessment. Philips IntelliSpace PACS covers Diagnostic reading client, Zero footprint web viewer, Enterprise archive, Advanced visualisation.

Answered from the vendors’ own pages

Lunit: Is Lunit FDA cleared?

Yes for specific products. INSIGHT MMG, INSIGHT DBT and INSIGHT CXR Triage hold FDA 510(k) clearances. INSIGHT Risk, the five year risk prediction model, has been filed but was not cleared at the time of writing.

Philips IntelliSpace PACS: Is IntelliSpace PACS being discontinued?

It is still sold and supported, but Philips has moved its marketing to Philips Enterprise Imaging and some regional IntelliSpace product pages now redirect. Ask Philips for the written lifecycle statement before signing a multi year term.

Lunit: Can Lunit replace a second human reader in screening?

That depends entirely on your jurisdiction and professional body guidance, not on the software. The CE mark permits clinical use; it does not authorise a workforce model.

Philips IntelliSpace PACS: Can I run it in the cloud?

Yes. Philips lists IntelliSpace Radiology on AWS Marketplace, and Philips also offers a managed hosted deployment. Both are quoted rather than self service.

Lunit: What did the Volpara acquisition add?

Volumetric breast density measurement, dose tracking and RiskPathways high risk programme management, which are the things American breast centres buy for density notification compliance rather than for detection.

Philips IntelliSpace PACS: Does Philips publish pricing?

No. Pricing is by study volume, concurrent diagnostic users and storage, and is usually negotiated alongside modality capital.

Lunit: Is pricing published?

No. It is quoted per study or per annual volume, by product, with on premises and cloud priced differently.

Philips IntelliSpace PACS: Will it read images from non Philips scanners?

Yes, it is a standard DICOM archive and viewer. The gap is in advanced visualisation and modality workflow integration, which is deeper on Philips equipment.

Share

Related pages

More on Lunit

More on Philips IntelliSpace PACS

Keep looking

Other head to heads